AzTrials
AzTrials

Orthopaedic Decision MakingNCT02440529

Surgeon-Patient Communication: A Randomized Controlled Trial Evaluating the Impact of an Orthopaedic Related Smoking Cessation Discussion After Fracture Surgery

A study testing Intervention and Verbal Group in people with Orthopaedic Decision Making, run by University of Missouri, Kansas City at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

In this study, the investigators are interested in evaluating the impact of an orthopaedic related smoking cessation discussion after fracture surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Orthopaedic Decision Making
What is being tested?
Intervention and Verbal Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1 participants
Where
1 siteUnited States
Study dates
Jan 2016to Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients 18 year old or older,
  • daily smoker
  • inpatient post fracture operation,
  • patient that have never received an orthopaedic related smoking cessation discussion

Who cannot join

  • Younger than 18,
  • patients unable to provide consent
  • patients that suffer from auditory/visual/mental disability requiring another individual as a decision-maker

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Truman Medical Center

    Kansas City, Missouri, 64108

Other trials in United States

About this study

In this study, the investigators are interested in evaluating the impact of an orthopaedic related smoking cessation discussion after fracture surgery.

Being tested
Intervention, Verbal Group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionBehavioural

    Discussion

  • Verbal GroupBehavioural

    Detailed Discussion

Study groups in NCT02440529
Study groupRoleWhat they receive
(Intervention Group)Active comparatorThe discussion about how smoking cigarettes impacts patient orthopaedic management plus aid
Receives: Behavioral: Intervention
(Control Group)Active comparatorThe discussion about how smoking cigarettes impacts patient orthopaedic management.
Receives: Behavioral: Verbal Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Comprehension

    Knowledge-Based Question

    Measured: 20 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2015 (estimated)
  2. Study startJan 2016
  3. Primary completionApr 2018
  4. Study completionApr 2018

Why it stopped: Research staff decision

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02440529
Sponsor's protocol ID
15-248
Status last verified
Apr 2018
First submitted
7 May 2015
Last updated
26 Apr 2018
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention and Verbal Group in people with Orthopaedic Decision Making, run by University of Missouri, Kansas City at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Research staff decision). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Comprehension (time frame: 20 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in